Radiofrequency ablation methods for uterine sparing fibroid treatment

Curr Opin Obstet Gynecol. 2022 Aug 1;34(4):262-269. doi: 10.1097/GCO.0000000000000801.

Abstract

Purpose of review: This article provides a clinical review of radiofrequency ablation (RFA) for the treatment of uterine leiomyomas.

Recent findings: RFA is an effective and durable treatment for fibroids with sustained improvements in fibroid volume, bleeding, and patient reported outcomes with low reintervention rates. Although fertility data is limited, it is overall positive and may represent a uterine conserving and fertility preserving treatment modality.

Summary: RFA is a safe and effective uterine preserving treatment option for symptomatic leiomyomas.

Publication types

  • Review

MeSH terms

  • Catheter Ablation* / methods
  • Female
  • Humans
  • Leiomyoma* / surgery
  • Radiofrequency Ablation* / methods
  • Treatment Outcome
  • Uterine Neoplasms* / surgery